Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA approves IND for M6G

April 30, 2007

Recent patents describe new analgesic agents

April 30, 2007

Istradefylline NDA filed for Parkinson's disease

April 27, 2007

XP-13512 shows improvements in RLS

April 27, 2007

BEMA Fentanyl meets primary endpoint in breakthrough cancer pain

April 27, 2007

VSF-173 studied in phase II for excessive sleepiness

April 27, 2007

Recent patents describe novel agents for psychopharmacological disorders

April 27, 2007

Neuromed licenses U.S. rights to OROS Hydromorphone

April 27, 2007

Phase IIa results for i.v. cannabinor in postoperative pain

April 26, 2007

Miraxion fails to meet endpoints in phase III Huntington's studies

April 26, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...